Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Subject Area, Categories, Scope||Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1)|
|SCImago Journal Rank (SJR)||2.571|
|Publisher||BioMed Central Ltd.|
Translational Neurodegeneration is a journal covering the technologies/fields/categories related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1). It is published by BioMed Central Ltd.. The overall rank of Translational Neurodegeneration is 835. According to SCImago Journal Rank (SJR), this journal is ranked 2.571. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 54. The best quartile for this journal is Q1.
The ISSN of Translational Neurodegeneration journal is 20479158. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Translational Neurodegeneration is cited by a total of 1382 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Translational Neurodegeneration is 10.88, which is computed in 2023 as per its definition. Translational Neurodegeneration IF is increased by a factor of 1.9 and approximate percentage change is 21.16% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Translational Neurodegeneration is 10.88. If the same upward trend persists, Impact IF may rise in 2023 as well.
Translational Neurodegeneration has an h-index of 54. It means 54 articles of this journal have more than 54 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Translational Neurodegeneration is 20479158. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Translational Neurodegeneration is 835. According to SCImago Journal Rank (SJR), this journal is ranked 2.571. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Translational Neurodegeneration is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Translational Neurodegeneration is Transl. Neurodegener.. This abbreviation ('Transl. Neurodegener.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Translational Neurodegeneration latest impact IF is 10.88. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 10.88 (2022) and 3.23 (2015), respectively, in the last 9 years. Moreover, its average IS is 6.44 in the previous 9 years.
The Translational Neurodegeneration has an SJR (SCImago Journal Rank) of 2.571, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.571 in 2022 and the lowest being 1.461 in 2015. Furthermore, the average SJR of the Translational Neurodegeneration over the previous 9-year period stands at 6.44.
The latest h-index of the Translational Neurodegeneration is 54.
The Translational Neurodegeneration is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.
The Translational Neurodegeneration is currently ranked 835 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 835 in 2022 and its lowest position of 2505 in 2015.
The standard ISO4 abbreviation for the Translational Neurodegeneration is Transl. Neurodegener..
Translational Neurodegeneration is classified as a journal that the BioMed Central Ltd. publishes.
The Translational Neurodegeneration encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Translational Neurodegeneration is assigned the following International Standard Serial Numbers (ISSN): 20479158.
The best quartile for the Translational Neurodegeneration is Q1 (2022).
The Translational Neurodegeneration coverage history can be summarized as follows: 2012-2022.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Journal of Competition Law and Economics||journal||14815||Oxford University Press||29||0.72|
|Journal of Applied Business Research||journal||23890||29||0.28|
|Canadian Journal of Education||journal||17961||Canadian Society for the Study of Education (CSSE)||41||0.39|
|Howard Journal of Communications||journal||9564||Taylor and Francis Ltd.||36||1.66|
|Tekstilec||trade journal||19217||Faculty of Natural Sciences and Engineering, Tekstilec||14||0.73|
|Exploration Geophysics||journal||16383||Taylor and Francis Ltd.||48||1.17|
|Proceedings of the Technical Association of the Graphic Arts, TAGA||conference and proceedings||30903||Technical Association of the Graphic||8||0.00|
|Biological Procedures Online||journal||3350||BioMed Central Ltd.||43||6.40|
|Museum Management and Curatorship||journal||8168||Routledge||37||2.65|
|Year||Impact Score (IS)|